JPMorgan has downgraded the stock to “underweight” from “overweight” following a significant of share price outperformance, and a reassessment of risks facing the company’s medium term outlook.
JPMorgan has downgraded the stock to “underweight" from “overweight" following share price outperformance and a reassessment of risks facing the company’s medium-term outlook.
Analysts noted that MCE had rallied by 80 per cent in less than three months, and by almost 400 per cent since its initial public offering in November 2009.
